(Q45857523)

17 December 2017

title

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity (English)

1 reference

17 December 2017

1 reference

18

Jaap Goudsmit

1 reference

17 December 2017

4

Peter Abbink

1 reference

17 December 2017

19

Dan H Barouch

1 reference

17 December 2017

Darci A Gorgone

10

Darci A Gorgone

1 reference

17 December 2017

Michelle A Lifton

11

Michelle A Lifton

1 reference

17 December 2017

Angelique Lemckert

12

Angelique A C Lemckert

1 reference

17 December 2017

Keith G Mansfield

17

Keith G Mansfield

1 reference

17 December 2017

Menzo Havenga

3

Menzo J E Havenga

1 reference

17 December 2017

Angela A L Carville

16

Angela Carville

1 reference

17 December 2017

Lennart Holterman

13

Lennart Holterman

1 reference

17 December 2017

Anjali Nanda

2

Anjali Nanda

1 reference

17 December 2017

Bonnie A Ewald

6

Bonnie A Ewald

1 reference

17 December 2017

author name string

Diane M Roberts

1

1 reference

17 December 2017

Diana M Lynch

5

1 reference

17 December 2017

Jinyan Liu

7

1 reference

17 December 2017

Anna R Thorner

8

1 reference

17 December 2017

Patricia E Swanson

9

1 reference

17 December 2017

Bing Chen

14

1 reference

17 December 2017

Athmanundh Dilraj

15

1 reference

17 December 2017

language of work or name

English

0 references

publication date

16 April 2006

1 reference

17 December 2017

published in

Nature

1 reference

17 December 2017

volume

441

1 reference

17 December 2017

issue

7090

1 reference

17 December 2017

page(s)

239-243

1 reference

17 December 2017

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

Development and homeostasis of T cell memory in rhesus macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Hexon gene switch strategy for the generation of chimeric recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Improved adenovirus vectors for infection of cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04721

7 January 2021

Identifiers

DOI

10.1038/NATURE04721

1 reference

17 December 2017

Dimensions Publication ID

1050800201

0 references

1 reference

17 December 2017